ENTITY
Lupin Ltd

Lupin Ltd (LPC IN)

244
Analysis
Health CareIndia
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
more
02 Sep 2025 20:53Broker

Axis Top Picks for the month of September 2025

Axis Top Picks Basket delivered a return of 16.2% in the last six months against the 10.4% returns posted by Nifty 50, outperforming the Nifty 50...

Logo
223 Views
Share
02 Sep 2025 20:46Broker

Axis Intellect - Balanced

Stock investment endeavors to deliver consistent outperformance over the long term by making a diversified investment of ‘Winners

Logo
221 Views
Share
02 Sep 2025 20:37Broker

Axis Intellect - Aggressive

Stock investment endeavours to deliver consistent outperformance in the long term by making a diversified investment of ‘Winners’.

Logo
236 Views
Share
24 Aug 2025 08:32Broker

Quarterly Flipbook: Earnings growth and downgrade cycle bottoming-out

The aggregate performance of the Q1FY26 earnings season was steady as sequential improvement in YoY PAT growth continued in the current quarter

Logo
231 Views
Share
13 Aug 2025 05:11Broker

Pharmaceuticals: IPM: 7% value and 2% unit decline in Jul-25

As per IQVIA, IPM saw 7.1% YoY growth in Jul-25 on a high base of 11.7% growth in Jul-24 (~11.5% YoY in Jun’25, 9% YoY in Q1FY26, and 8% in FY25)...

Logo
177 Views
Share
x